Literature DB >> 25529795

p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma.

Heather L Lehman1, Xuebin Yang1, Patricia A Welsh1, Douglas B Stairs2.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with a poor prognosis due to its highly invasive and metastatic potential. The molecular pathogenesis underlying the invasive mechanism of ESCC is not well known because of the lack of existing models to study this disease. p120-Catenin (p120ctn) and the epidermal growth factor receptor (EGFR) have each been implicated in several cancers, including ESCC. p120ctn is down-regulated in 60% of ESCC tumors, whereas EGFR is the most commonly overexpressed oncogene in ESCC. For these reasons, we investigated the cooperation between p120ctn and EGFR and its effect on ESCC invasion. We show that p120ctn down-regulation is commonly associated with EGFR overexpression. By using a three-dimensional culture system, we demonstrate that the inverse relationship between p120ctn and EGFR has biological implications. Specifically, p120ctn down-regulation coupled with EGFR overexpression in human esophageal keratinocytes (EPC1-PE) was required to promote invasion. Morphological comparison of EPC1-PE cells grown in three-dimensional culture and human ESCC revealed identical features, including significantly increased cellularity, nuclear grade, and proliferation. Molecular characteristics were measured by keratin expression patterns, which were nearly identical between EPC1-PE cells in three-dimensional culture and ESCC samples. Altogether, our analyses have demonstrated that p120ctn down-regulation and EGFR overexpression are able to mimic human ESCC in a relevant three-dimensional culture model.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25529795      PMCID: PMC4278242          DOI: 10.1016/j.ajpath.2014.09.008

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

Review 1.  Keratins in health and cancer: more than mere epithelial cell markers.

Authors:  V Karantza
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

2.  A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma.

Authors:  Joon-Yong Chung; Till Braunschweig; Nan Hu; Mark Roth; June L Traicoff; Quan-Hong Wang; Vladimir Knezevic; Philip R Taylor; Stephen M Hewitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

3.  Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.

Authors:  Claudia D Andl; Takaaki Mizushima; Hiroshi Nakagawa; Kenji Oyama; Hideki Harada; Katerina Chruma; Meenhard Herlyn; Anil K Rustgi
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

4.  p120-catenin is essential for terminal end bud function and mammary morphogenesis.

Authors:  Sarah J Kurley; Brian Bierie; Robert H Carnahan; Nichole A Lobdell; Michael A Davis; Ilse Hofmann; Harold L Moses; William J Muller; Albert B Reynolds
Journal:  Development       Date:  2012-03-29       Impact factor: 6.868

Review 5.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

6.  Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction.

Authors:  Bas P L Wijnhoven; Massimo Pignatelli; Winand N M Dinjens; Hugo W Tilanus
Journal:  J Surg Oncol       Date:  2005-11-01       Impact factor: 3.454

7.  Cytokeratin immunoexpression in esophageal squamous cell carcinoma of high-risk population in Northeast India.

Authors:  Avninder Singh; Sujala Kapur; Indranil Chattopadhyay; Joydeep Purkayastha; Jagannath Sharma; Ashwani Mishra; Stephen M Hewitt; Sunita Saxena
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-10

8.  Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.

Authors:  Li-yan Xue; Nan Hu; Yong-mei Song; Shuang-mei Zou; Jian-zhong Shou; Lu-xia Qian; Li-qun Ren; Dong-mei Lin; Tong Tong; Zu-gen He; Qi-min Zhan; Philip R Taylor; Ning Lu
Journal:  BMC Cancer       Date:  2006-12-22       Impact factor: 4.430

9.  Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

Authors:  P Lipponen; M Eskelinen
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

10.  Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus.

Authors:  T Makino; M Yamasaki; A Takeno; M Shirakawa; H Miyata; S Takiguchi; K Nakajima; Y Fujiwara; T Nishida; N Matsuura; M Mori; Y Doki
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more
  9 in total

1.  p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling.

Authors:  Lusha Li; Shangli Ji; Chandrama Shrestha; Yi Jiang; Liyan Liao; Feng Xu; Zhenming Liu; Daniel D Bikle; Zhongjian Xie
Journal:  J Cell Physiol       Date:  2020-04-30       Impact factor: 6.384

2.  Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma.

Authors:  W Zhang; R Hong; L Xue; Y Ou; X Liu; Z Zhao; W Xiao; D Dong; L Dong; M Fu; L Ma; N Lu; H Chen; Y Song; Q Zhan
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

3.  The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.

Authors:  Weimin Zhang; Ruoxi Hong; Lin Li; Yan Wang; Peina Du; Yunwei Ou; Zitong Zhao; Xuefeng Liu; Wenchang Xiao; Dezuo Dong; Qingnan Wu; Jie Chen; Yongmei Song; Qimin Zhan
Journal:  Mol Cancer       Date:  2018-08-21       Impact factor: 27.401

4.  Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes.

Authors:  Heather L Lehman; Michal Kidacki; Douglas B Stairs
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

5.  Black raspberry restores the expression of the tumor suppressor p120ctn in the oral cavity of mice treated with the carcinogen dibenzo[a,l]pyrene diol epoxide.

Authors:  Douglas B Stairs; Mary E Landmesser; Cesar Aliaga; Kun-Ming Chen; Yuan-Wan Sun; Karam El-Bayoumy
Journal:  PLoS One       Date:  2021-11-16       Impact factor: 3.240

6.  NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation.

Authors:  Heather L Lehman; Michal Kidacki; Joshua I Warrick; Douglas B Stairs
Journal:  Oncotarget       Date:  2018-01-29

Review 7.  Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine.

Authors:  Kelly A Whelan; Amanda B Muir; Hiroshi Nakagawa
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-01-31

8.  Novel truncating mutations in CTNND1 cause a dominant craniofacial and cardiac syndrome.

Authors:  Reham Alharatani; Athina Ververi; Ana Beleza-Meireles; Weizhen Ji; Emily Mis; Quinten T Patterson; John N Griffin; Nabina Bhujel; Caitlin A Chang; Abhijit Dixit; Monica Konstantino; Christopher Healy; Sumayyah Hannan; Natsuko Neo; Alex Cash; Dong Li; Elizabeth Bhoj; Elaine H Zackai; Ruth Cleaver; Diana Baralle; Meriel McEntagart; Ruth Newbury-Ecob; Richard Scott; Jane A Hurst; Ping Yee Billie Au; Marie Therese Hosey; Mustafa Khokha; Denise K Marciano; Saquib A Lakhani; Karen J Liu
Journal:  Hum Mol Genet       Date:  2020-07-21       Impact factor: 6.150

9.  Loss of p120ctn causes EGFR-targeted therapy resistance and failure.

Authors:  Mary E Landmesser; Wesley M Raup-Konsavage; Heather L Lehman; Douglas B Stairs
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.